Alector, Inc. (ALEC) stock
ALECNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
$2.57+0.01 (+0.39%)
Close on Nov 18, 2026Market cap $286.96MP/E –Yield –
Alector operating income
Operating income is the profit from the core business after operating expenses such as R&D and selling costs, before interest and taxes.
Alector's operating income for the twelve months ending Jun 30, 2026 was -$126.49M. For fiscal 2025 it was -$156.01M. The highest annual figure on record is -$32.68M in fiscal 2017.
Annual operating income
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | -$156.01M | – |
| FY2024 | Dec 31, 2024 | -$145.00M | – |
| FY2023 | Dec 31, 2023 | -$151.74M | – |
| FY2022 | Dec 31, 2022 | -$137.83M | – |
| FY2021 | Dec 31, 2021 | -$37.36M | – |
| FY2020 | Dec 31, 2020 | -$195.17M | – |
| FY2019 | Dec 31, 2019 | -$114.40M | – |
| FY2018 | Dec 31, 2018 | -$57.29M | – |
| FY2017 | Dec 31, 2017 | -$32.68M | – |
Quarterly operating income
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | -$24.39M | – |
| Q1 FY2026 | Mar 31, 2026 | -$24.92M | – |
| Q4 FY2025 | Dec 31, 2025 | -$39.57M | – |
| Q3 FY2025 | Sep 30, 2025 | -$37.61M | – |
| Q2 FY2025 | Jun 30, 2025 | -$34.14M | – |
| Q1 FY2025 | Mar 31, 2025 | -$44.70M | – |
| Q4 FY2024 | Dec 31, 2024 | -$7.25M | – |
| Q3 FY2024 | Sep 30, 2024 | -$48.43M | – |
| Q2 FY2024 | Jun 30, 2024 | -$45.61M | – |
| Q1 FY2024 | Mar 31, 2024 | -$43.71M | – |
| Q4 FY2023 | Dec 31, 2023 | -$47.45M | – |
| Q3 FY2023 | Sep 30, 2023 | -$50.58M | – |
| Q2 FY2023 | Jun 30, 2023 | -$3.59M | -137.9% |
| Q1 FY2023 | Mar 31, 2023 | -$50.12M | – |
| Q4 FY2022 | Dec 31, 2022 | -$55.44M | – |
| Q3 FY2022 | Sep 30, 2022 | -$47.75M | -137.8% |
| Q2 FY2022 | Jun 30, 2022 | $9.48M | – |
| Q1 FY2022 | Mar 31, 2022 | -$44.12M | – |
| Q4 FY2021 | Dec 31, 2021 | -$55.73M | – |
| Q3 FY2021 | Sep 30, 2021 | $126.33M | – |
| Q2 FY2021 | Jun 30, 2021 | -$55.33M | – |
| Q1 FY2021 | Mar 31, 2021 | -$52.64M | – |
| Q4 FY2020 | Dec 31, 2020 | -$52.76M | – |
| Q3 FY2020 | Sep 30, 2020 | -$53.75M | – |
| Q2 FY2020 | Jun 30, 2020 | -$46.59M | – |
| Q1 FY2020 | Mar 31, 2020 | -$42.08M | – |
| Q4 FY2019 | Dec 31, 2019 | -$32.34M | – |
| Q3 FY2019 | Sep 30, 2019 | -$34.15M | – |
| Q2 FY2019 | Jun 30, 2019 | -$27.15M | – |
| Q1 FY2019 | Mar 31, 2019 | -$20.76M | – |
| Q4 FY2018 | Dec 31, 2018 | -$19.02M | – |
| Q3 FY2018 | Sep 30, 2018 | -$16.82M | – |
| Q2 FY2018 | Jun 30, 2018 | -$12.23M | – |
| Q1 FY2018 | Mar 31, 2018 | -$9.23M | – |
See a number that looks wrong?